During the past decade, Limited Liability Company "RC Medical" conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Limited Liability Company "RC Medical"" are "Esophageal Squamous Cell Carcinoma" (1 trials) and "Triple-Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Limited Liability Company "RC Medical"" in a lesser frequency.

Most popular intervention types in "Limited Liability Company "RC Medical"" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Atezolizumab Matching Placebo" (1 trials), "Ipatasertib" (1 trials), "Paclitaxel" (1 trials) and "Placebo for Atezolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Limited Liability Company "RC Medical"" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Limited Liability Company "RC Medical"". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Limited Liability Company "RC Medical", undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Limited Liability Company "RC Medical", 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".